Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Dr. Kumar from LifeWellMD.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Kumar from LifeWellMD.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How NAD+ Lowers Cholesterol—With or Without Statins

16:35
 
Share
 

Manage episode 477630175 series 3606011
Content provided by Dr. Kumar from LifeWellMD.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Kumar from LifeWellMD.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

Navigating the complex landscape of NAD+ precursors just got easier. We're cutting through scientific noise to examine a massive meta-analysis combining 40 clinical studies with nearly 15,000 participants that reveals surprising truths about these popular supplements and their effects on cholesterol.
NAD+ isn't just another molecule—it's an essential coenzyme powering countless processes throughout your body, particularly fatty acid and cholesterol metabolism. The precursors that help your body produce NAD+—nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), nicotinic acid (NA), and nicotinamide (NAM)—have generated tremendous interest in health circles, but with wildly varying claims about their benefits.
Our deep dive reveals that while these precursors collectively improved lipid profiles (reducing triglycerides, total cholesterol, LDL, and increasing HDL), the benefits weren't universal. The most striking finding? NAD+ precursors showed minimal impact in healthy individuals but produced significant improvements in those with existing cardiovascular disease or dyslipidemia. Nicotinic acid (niacin) emerged as the clear frontrunner for lipid management, working through multiple pathways to improve cholesterol markers and demonstrating real clinical benefits including reduced cardiovascular mortality.
We also explore the potential tradeoff—a slight increase in blood glucose levels associated with some precursors—and the evolving research suggesting NAM might offer lipid benefits without this downside. Whether you're considering supplementation or simply fascinated by metabolic health, this evidence-based exploration provides crucial context for understanding how these molecules might fit into your health strategy. What role might supporting NAD+ levels play in your long-term wellness plan?

Disclaimer:
The information provided in this podcast is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making changes to your supplement regimen or health routine. Individual needs and reactions vary, so it’s important to make informed decisions with the guidance of your physician.
Connect with Us:
If you enjoyed today’s episode, be sure to subscribe, leave us a review, and share it with someone who might benefit. For more insights and updates, visit our website at Lifewellmd.com.
Stay Informed, Stay Healthy:
Remember, informed choices lead to better health. Until next time, be well and take care of yourself.

  continue reading

Chapters

1. How NAD+ Lowers Cholesterol—With or Without Statins (00:00:00)

2. Introduction to NAD+ Deep Dive (00:00:36)

3. Understanding NAD+ and Its Functions (00:01:33)

4. Sirtuins and Their Metabolic Importance (00:03:37)

5. Four Major NAD+ Precursors Explained (00:04:50)

6. Meta-Analysis Results on Lipid Markers (00:05:33)

7. Nicotinic Acid's Proven Cholesterol Benefits (00:07:03)

8. NR and NAM: Emerging Research (00:09:28)

9. Who Benefits Most from Supplementation (00:12:26)

10. Study Limitations and Future Research (00:14:20)

11. Key Takeaways and Final Thoughts (00:16:33)

107 episodes

Artwork
iconShare
 
Manage episode 477630175 series 3606011
Content provided by Dr. Kumar from LifeWellMD.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Kumar from LifeWellMD.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

Navigating the complex landscape of NAD+ precursors just got easier. We're cutting through scientific noise to examine a massive meta-analysis combining 40 clinical studies with nearly 15,000 participants that reveals surprising truths about these popular supplements and their effects on cholesterol.
NAD+ isn't just another molecule—it's an essential coenzyme powering countless processes throughout your body, particularly fatty acid and cholesterol metabolism. The precursors that help your body produce NAD+—nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), nicotinic acid (NA), and nicotinamide (NAM)—have generated tremendous interest in health circles, but with wildly varying claims about their benefits.
Our deep dive reveals that while these precursors collectively improved lipid profiles (reducing triglycerides, total cholesterol, LDL, and increasing HDL), the benefits weren't universal. The most striking finding? NAD+ precursors showed minimal impact in healthy individuals but produced significant improvements in those with existing cardiovascular disease or dyslipidemia. Nicotinic acid (niacin) emerged as the clear frontrunner for lipid management, working through multiple pathways to improve cholesterol markers and demonstrating real clinical benefits including reduced cardiovascular mortality.
We also explore the potential tradeoff—a slight increase in blood glucose levels associated with some precursors—and the evolving research suggesting NAM might offer lipid benefits without this downside. Whether you're considering supplementation or simply fascinated by metabolic health, this evidence-based exploration provides crucial context for understanding how these molecules might fit into your health strategy. What role might supporting NAD+ levels play in your long-term wellness plan?

Disclaimer:
The information provided in this podcast is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making changes to your supplement regimen or health routine. Individual needs and reactions vary, so it’s important to make informed decisions with the guidance of your physician.
Connect with Us:
If you enjoyed today’s episode, be sure to subscribe, leave us a review, and share it with someone who might benefit. For more insights and updates, visit our website at Lifewellmd.com.
Stay Informed, Stay Healthy:
Remember, informed choices lead to better health. Until next time, be well and take care of yourself.

  continue reading

Chapters

1. How NAD+ Lowers Cholesterol—With or Without Statins (00:00:00)

2. Introduction to NAD+ Deep Dive (00:00:36)

3. Understanding NAD+ and Its Functions (00:01:33)

4. Sirtuins and Their Metabolic Importance (00:03:37)

5. Four Major NAD+ Precursors Explained (00:04:50)

6. Meta-Analysis Results on Lipid Markers (00:05:33)

7. Nicotinic Acid's Proven Cholesterol Benefits (00:07:03)

8. NR and NAM: Emerging Research (00:09:28)

9. Who Benefits Most from Supplementation (00:12:26)

10. Study Limitations and Future Research (00:14:20)

11. Key Takeaways and Final Thoughts (00:16:33)

107 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play